Owens & Minor, Inc. (NYSE:OMI) Given Average Recommendation of “Hold” by Brokerages

Owens & Minor, Inc. (NYSE:OMI) has earned a consensus recommendation of “Hold” from the eight research firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $20.00.

Several analysts have recently issued reports on the company. Citigroup upgraded Owens & Minor from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $24.00 to $19.00 in a research note on Friday, July 19th. StockNews.com downgraded Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Bank of America decreased their price target on Owens & Minor from $18.00 to $16.00 and set an “underperform” rating for the company in a research note on Tuesday, June 25th. Barclays decreased their target price on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating for the company in a research note on Monday, August 5th. Finally, Robert W. Baird decreased their target price on Owens & Minor from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Tuesday, July 16th.

Owens & Minor Stock Performance

Shares of OMI stock opened at $15.81 on Thursday. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.09 and a quick ratio of 0.51. Owens & Minor has a fifty-two week low of $12.36 and a fifty-two week high of $28.35. The stock’s 50-day moving average is $15.36 and its two-hundred day moving average is $19.00. The firm has a market cap of $1.21 billion, a P/E ratio of -31.00, a PEG ratio of 0.47 and a beta of 0.39.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Friday, August 2nd. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.03. The company had revenue of $2.67 billion during the quarter, compared to the consensus estimate of $2.65 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The firm’s revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.18 EPS. Analysts predict that Owens & Minor will post 1.57 earnings per share for the current fiscal year.

Institutional Trading of Owens & Minor

Several institutional investors have recently modified their holdings of OMI. Riverview Trust Co acquired a new stake in shares of Owens & Minor during the 1st quarter worth approximately $25,000. Quarry LP lifted its position in shares of Owens & Minor by 290.1% during the 2nd quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after buying an additional 1,561 shares during the period. Quest Partners LLC bought a new position in shares of Owens & Minor during the 4th quarter worth approximately $41,000. Hexagon Capital Partners LLC lifted its position in shares of Owens & Minor by 1,240.2% during the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock worth $43,000 after buying an additional 1,451 shares during the period. Finally, Innealta Capital LLC bought a new position in shares of Owens & Minor during the 2nd quarter worth approximately $43,000. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.